SCHEMBL29800145

SCHEMBL29800145

COC(=O)c1c(N(CCc2ccccc2F)C(C)=O)sc2c(CN(C)C)c(O)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 1/20 0.36
▸ HSP90AA1 P07900 3/20 0.35
▸ HSP90B1 P14625 2/20 0.35
▸ KDM4E B2RXH2 4/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ HPGD P15428 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ AOC3 Q16853 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ PKM P14618 1/20 0.32
▸ ACKR3 P25106 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24683891 1.00 TAAR1 (0.36) TAAR1HSP90AA1HSP90B1KDM4EALDH1A1
SCHEMBL24683840 0.93 KDM4E (0.34) HSP90AA1HSP90B1KDM4EALDH1A1HPGD
SCHEMBL24683224 0.87 HSP90AA1 (0.39) TAAR1HSP90AA1HSP90B1KDM4EALDH1A1
SCHEMBL30664668 0.87 HSP90AA1 (0.39) TAAR1HSP90AA1HSP90B1KDM4EALDH1A1
SCHEMBL24683842 0.86 HSP90AA1 (0.37) HSP90AA1HSP90B1KDM4EALDH1A1HPGD
SCHEMBL24682963 0.84 KMT2A (0.34) HSP90AA1HSP90B1KDM4EALDH1A1HPGD
SCHEMBL24683206 0.84 LMNA (0.38) HSP90AA1HSP90B1KDM4EALDH1A1HPGD
SCHEMBL24683871 0.83 POLB (0.37) HSP90AA1HSP90B1KDM4EALDH1A1HPGD
SCHEMBL24682191 0.83 NPSR1 (0.36) HSP90AA1KDM4EALDH1A1HPGDGAA
SCHEMBL24682827 0.82 RIPK1 (0.34) HSP90AA1HSP90B1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed
WO-2022173329-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Акционерное общество "Отисифарм" 2022-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 TAAR1 2290/4885HSP90AA1 890/4885HSP90B1 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback